Dare Bioscience Inc
NASDAQ:DARE

Watchlist Manager
Dare Bioscience Inc Logo
Dare Bioscience Inc
NASDAQ:DARE
Watchlist
Price: 2.28 USD -4.2%
Market Cap: 32.6m USD

Wall Street
Price Targets

DARE Price Targets Summary
Dare Bioscience Inc

Wall Street analysts forecast DARE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DARE is 10.97 USD with a low forecast of 8.08 USD and a high forecast of 12.6 USD.

Lowest
Price Target
8.08 USD
254% Upside
Average
Price Target
10.97 USD
381% Upside
Highest
Price Target
12.6 USD
453% Upside
Dare Bioscience Inc Competitors:
Price Targets
MEGA
Mega Lifesciences PCL
5% Upside
000513
Livzon Pharmaceutical Group Inc
31% Upside
INVA
Innoviva Inc
63% Upside
STX
Shield Therapeutics PLC
39% Upside
326030
SK Biopharmaceuticals Co Ltd
14% Upside
002821
Asymchem Laboratories Tianjin Co Ltd
31% Upside
4523
Eisai Co Ltd
14% Upside

Revenue
Forecast

Revenue Estimate
Dare Bioscience Inc

For the last 12 years the compound annual growth rate for Dare Bioscience Inc's revenue is -29%. The projected CAGR for the next 4 years is 1 042%.

-29%
Past Growth
1 042%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Dare Bioscience Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Dare Bioscience Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DARE's stock price target?
Price Target
10.97 USD

According to Wall Street analysts, the average 1-year price target for DARE is 10.97 USD with a low forecast of 8.08 USD and a high forecast of 12.6 USD.

What is Dare Bioscience Inc's Revenue forecast?
Projected CAGR
1 042%

For the last 12 years the compound annual growth rate for Dare Bioscience Inc's revenue is -29%. The projected CAGR for the next 4 years is 1 042%.

Back to Top